Lord, Abbett & Co. LLC Myovant Sciences Ltd. Transaction History

Lord, Abbett & Co. LLC

$30.7 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.78 - $14.69 $2.61 Million - $4.93 Million	-335,527 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$11.38 - $16.4 $897,950 - $1.29 Million	-78,906 Reduced 19.04%	335,527 $4.47 Million
Q4 2021 Feb 11, 2022	SELL	$14.31 - $23.87 $1.63 Million - $2.71 Million	-113,678 Reduced 21.53%	414,433 $6.45 Million
Q3 2021 Nov 09, 2021	SELL	$18.94 - $26.99 $111,897 - $159,456	-5,908 Reduced 1.11%	528,111 $11.9 Million
Q2 2021 Aug 11, 2021	SELL	$17.07 - $24.56 $22.4 Million - $32.2 Million	-1,311,460 Reduced 71.06%	534,019 $12.2 Million
Q1 2021 May 11, 2021	SELL	$20.46 - $25.18 $307,268 - $378,153	-15,018 Reduced 0.81%	1,845,479 $38 Million
Q4 2020 Feb 09, 2021	BUY	$13.8 - $27.62 $490,383 - $981,476	35,535 Added 1.95%	1,860,497 $51.4 Million
Q3 2020 Nov 12, 2020	BUY	$14.05 - $22.6 $6.3 Million - $10.1 Million	448,739 Added 32.61%	1,824,962 $25.6 Million
Q2 2020 Aug 14, 2020	SELL	$7.34 - $20.84 $3.82 Million - $10.8 Million	-520,137 Reduced 27.43%	1,376,223 $28.4 Million
Q1 2020 May 14, 2020	BUY	$6.55 - $14.76 $215,888 - $486,489	32,960 Added 1.77%	1,896,360 $14.3 Million
Q4 2019 Feb 14, 2020	BUY	$4.2 - $19.21 $3.65 Million - $16.7 Million	868,893 Added 87.37%	1,863,400 $28.9 Million
Q3 2019 Nov 14, 2019	SELL	$5.19 - $9.46 $5.09 Million - $9.27 Million	-979,953 Reduced 49.63%	994,507 $5.17 Million
Q2 2019 Aug 14, 2019	BUY	$8.69 - $25.0 $76,080 - $218,875	8,755 Added 0.45%	1,974,460 $17.9 Million
Q1 2019 May 15, 2019	BUY	$16.83 - $24.45 $877,802 - $1.28 Million	52,157 Added 2.73%	1,965,705 $46.9 Million
Q4 2018 Feb 14, 2019	BUY	$15.01 - $25.2 $250,186 - $420,033	16,668 Added 0.88%	1,913,548 $31.4 Million
Q3 2018 Nov 14, 2018	BUY	$19.33 - $26.78 $14.2 Million - $19.7 Million	734,870 Added 63.24%	1,896,880 $50.4 Million
Q2 2018 Aug 14, 2018	BUY	$19.2 - $25.14 $19.5 Million - $25.5 Million	1,015,304 Added 692.07%	1,162,010 $26.6 Million
Q1 2018 May 15, 2018	BUY	$12.46 - $21.32 $1.83 Million - $3.13 Million	146,706 New	146,706 $3.12 Million

Others Institutions Holding MYOV

# of Institutions

Shares Held

61.3K

Call Options Held

Put Options Held

View Full List

About Myovant Sciences Ltd.

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

More about MYOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account